An experimental Alzheimer’s drug therapy has slowed cognitive and functional decline by 27% versus placebo in a double-blind, randomized study of 1,795 individuals with early signs and symptoms of the disease.

The boon comes in the form of greater brain cortical thickness observable on neonatal MRI two weeks after the baby enters the world.

Collectors of medical memorabilia may want to plan on preserving the January 2023 print edition of Radiology.

A pharmaceutical compound approved 21 years ago to treat breast cancer in postmenopausal women is showing fresh promise as a therapy for glioblastomas. 

Researchers in the U.K. have documented fetuses smiling when exposed to sweet flavors and frowning over bitter tastes.